Horiuchi, D; Kusdra, L; Huskey, NE; Chandriani, S; Lenburg, ME; Gonzalez-Angulo, AM; et al.(2012). MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. Journal of Experimental Medicine, 209(4), 679-696. doi: 10.1084/jem.20111512. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4q1317r7 The Journal of Experimental Medicine The Journal of experimental medicine, vol 209, iss 4